Czech Republic | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Czech Republic totalled $ 4.15 billion in 2023. Sales of commodity group 30 from Czech Republic went up by 11.7% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 436 million (cumulative exports of commodity group 30 from Czech Republic amounted $3.71 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 1.63% of total exports from Czech Republic (cumulative merchandise exports from Czech Republic totalled $ 253 billion in 2023). The share of commodity group 30 in total exports from Czech Republic increased by 0.101 p.p. compared to 2022 (it was 1.53% in 2022 and cumulative exports from Czech Republic were equal to $ 241 billion).
Where does Czech Republic export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Czech Republic in 2023:
- Germany with a share of 26% (1.11 billion US$)
- Slovak Republic with a share of 13.8% (574 million US$)
- Denmark with a share of 10.8% (449 million US$)
- Austria with a share of 6.07% (252 million US$)
- Hungary with a share of 4.51% (187 million US$)
- Poland with a share of 4.11% (170 million US$)
- United Kingdom with a share of 3.87% (160 million US$)
- USA with a share of 3.59% (149 million US$)
- Netherlands with a share of 3.49% (145 million US$)
- Russia with a share of 2.94% (122 million US$)
Exports structure of 30 - Pharmaceutical products - from Czech Republic in 2023 represented by the following main commodity groups:
- 71% (2.94 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 15.4% (641 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 8.4% (348 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 2.68% (111 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 2.14% (88 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.254% (10.5 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Czech Republic totalled $ 7.43 billion in 2023. Sales of commodity group 30 to Czech Republic went up by 5.61% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 395 million (the value of imports of commodity group 30 to Czech Republic was equal to $7.04 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 3.24% of total import flow to Czech Republic (in 2023, total imports to Czech Republic amounted to $ 228 billion). The share of commodity group 30 in total imports to Czech Republic increased by 0.269 p.p. compared to 2022 (it was 2.98% in 2022 and cumulative imports to Czech Republic were equal to $ 236 billion).
Where does Czech Republic import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Czech Republic in 2023:
- Germany with a share of 20% (1.49 billion US$)
- Denmark with a share of 8.89% (661 million US$)
- France with a share of 8.34% (620 million US$)
- Switzerland with a share of 6.86% (510 million US$)
- USA with a share of 6.08% (452 million US$)
- Ireland with a share of 5.75% (428 million US$)
- Italy with a share of 5.02% (373 million US$)
- Netherlands with a share of 5% (372 million US$)
- Belgium with a share of 3.62% (269 million US$)
- Slovak Republic with a share of 3.02% (225 million US$)
Imports structure of 30 - Pharmaceutical products - to Czech Republic in 2023 represented by the following main commodity groups:
- 72% (5.35 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 23% (1.75 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 2.14% (159 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.38% (103 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.736% (54 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.049% (3.71 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
